메뉴 건너뛰기




Volumn 24, Issue 4, 2010, Pages 903-907

Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE INHIBITOR; MIXED LINEAGE LEUKEMIA PROTEIN;

EID: 77950934774     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.14     Document Type: Letter
Times cited : (12)

References (12)
  • 1
    • 0141634051 scopus 로고    scopus 로고
    • Origins of chromosome translocations in childhood leukaemia
    • Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 2003; 3: 639-649.
    • (2003) Nat Rev Cancer , vol.3 , pp. 639-649
    • Greaves, M.F.1    Wiemels, J.2
  • 2
    • 34447519040 scopus 로고    scopus 로고
    • A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): An observational study and a multicentre randomised trial
    • Pieters R, Schrappe M, De Lorenzo P, Hann I, De Rossi G, Felice M et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007; 370: 240-250.
    • (2007) Lancet , vol.370 , pp. 240-250
    • Pieters, R.1    Schrappe, M.2    De Lorenzo, P.3    Hann, I.4    De Rossi, G.5    Felice, M.6
  • 3
    • 33947430189 scopus 로고    scopus 로고
    • Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease?
    • Mann G, Cazzaniga G, van der Velden VH, Flohr T, Csinady E, Paganin M et al. Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: the 'big sister' of the infant disease? Leukemia 2007; 21: 642-646.
    • (2007) Leukemia , vol.21 , pp. 642-646
    • Mann, G.1    Cazzaniga, G.2    Van Der Velden, V.H.3    Flohr, T.4    Csinady, E.5    Paganin, M.6
  • 4
    • 33947430631 scopus 로고    scopus 로고
    • Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement
    • Jansen MW, Corral L, van der Velden VH, Panzer-Grumayer R, Schrappe M, Schrauder A et al. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia 2007; 21: 633-641.
    • (2007) Leukemia , vol.21 , pp. 633-641
    • Jansen, M.W.1    Corral, L.2    Van Der Velden, V.H.3    Panzer-Grumayer, R.4    Schrappe, M.5    Schrauder, A.6
  • 5
    • 0035942491 scopus 로고    scopus 로고
    • Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL
    • Reichel M, Gillert E, Angermuller S, Hensel JP, Heidel F, Lode M et al. Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL. Oncogene 2001; 20: 2900-2907.
    • (2001) Oncogene , vol.20 , pp. 2900-2907
    • Reichel, M.1    Gillert, E.2    Angermuller, S.3    Hensel, J.P.4    Heidel, F.5    Lode, M.6
  • 6
    • 0346753588 scopus 로고    scopus 로고
    • Reciprocal DNA topoisomerase II cleavage events at 5-TATTA-3 sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing
    • Whitmarsh RJ, Saginario C, Zhuo Y, Hilgenfeld E, Rappaport EF, Megonigal MD et al. Reciprocal DNA topoisomerase II cleavage events at 5-TATTA-3 sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing. Oncogene 2003; 22: 8448-8459.
    • (2003) Oncogene , vol.22 , pp. 8448-8459
    • Whitmarsh, R.J.1    Saginario, C.2    Zhuo, Y.3    Hilgenfeld, E.4    Rappaport, E.F.5    Megonigal, M.D.6
  • 8
    • 33644512771 scopus 로고    scopus 로고
    • Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations
    • Burmeister T, Marschalek R, Schneider B, Meyer C, Gokbuget N, Schwartz S et al. Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations. Leukemia 2006; 20: 451-457.
    • (2006) Leukemia , vol.20 , pp. 451-457
    • Burmeister, T.1    Marschalek, R.2    Schneider, B.3    Meyer, C.4    Gokbuget, N.5    Schwartz, S.6
  • 9
    • 33847234331 scopus 로고    scopus 로고
    • Spliced MLL fusions: A novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia
    • Meyer C, Burmeister T, Strehl S, Schneider B, Hubert D, Zach O et al. Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia. Leukemia 2007; 21: 588-590.
    • (2007) Leukemia , vol.21 , pp. 588-590
    • Meyer, C.1    Burmeister, T.2    Strehl, S.3    Schneider, B.4    Hubert, D.5    Zach, O.6
  • 10
    • 0028775357 scopus 로고
    • Infant leukemia, topoisomerase II inhibitors, and the MLL gene
    • Ross JA, Potter JD, Robison LL. Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J Natl Cancer Inst 1994; 86: 1678-1680.
    • (1994) J Natl Cancer Inst , vol.86 , pp. 1678-1680
    • Ross, J.A.1    Potter, J.D.2    Robison, L.L.3
  • 11
    • 0034234515 scopus 로고    scopus 로고
    • DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis
    • Strissel PL, Strick R, Tomek RJ, Roe BA, Rowley JD, Zeleznik-Le NJ. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. Hum Mol Genet 2000; 9: 1671-1679.
    • (2000) Hum Mol Genet , vol.9 , pp. 1671-1679
    • Strissel, P.L.1    Strick, R.2    Tomek, R.J.3    Roe, B.A.4    Rowley, J.D.5    Zeleznik-Le, N.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.